PHYSIOLOGY OF MENSTRUATION
Introduction :
Typically, a woman of childbearing age should menstruate every 28 days or so unless she's pregnant or moving into menopause. But numerous things can wrong with the normal menstrual cycle.
Definition:
Menstruation means cyclic uterine bleeding caused by shedding of progestational endometrium it occurs between menarche and menopause
Menstruation (also called menstrual bleeding, menses, or a period)
Characteristics of normal menstruation
1-Menarche: 10-16 years. average 13 years.
2-Duration: 2-7 days (<2days>7 days is menorrhagia
3-Amount: 30-80 ml., uses 3 napkins per day, >80 ml. is menorrhagia and < 30 ml. is hypomenorrhea.
4-Normally menstrual blood doesn’t coagulate as a result of secretion of fibrinolysin enzyme (plasmin) secreted by the endometrium.
5-Menstrual molimina refers to mild symptoms of 7-10 days before menstruation relieved once menstruation occurs exaggerated condition called (premenstrual syndrome).
The hypothalamic-pituitary-ovarian axis:
There are two main components of the menstrual cycle,
1. the changes that happen in the ovaries in response to pituitary hormones (the ovarian cycle)
2. and the variations that take place in the uterus,
but it is important to remember that both cycles work together simultaneously to produce the menstrual cycle.
Changes in cervical mucus also take place during the course of the menstrual cycle.
This topic includes menstruation:- its definition, anatomical aspects- follicular growth and atresia, germ cells, premodial follicle; menstrual cycle/ ovarian cycle:- definition, phases- recruitment of groups of follicles (premature phase), selection of dominant follicle and its maturation, ovulation, follicular atresia; Endometrial cycle:- division of endometrium- basal zone, functional zone and its phases- stage of regeneration, stage of proliferation, secretory phase, menstrual phase, mechanism of menstrual bleeding, role of prostaglandins, hormones in relation to ovarian and menstrual cycle, ovulation, luteal-follicular shift, menstrual symptoms, menstrual hygiene, anovular menstruation, artificial postponement; cervical cycle, vaginal cycle and general changes in follicular and luteal phase.
PHYSIOLOGY OF MENSTRUATION
Introduction :
Typically, a woman of childbearing age should menstruate every 28 days or so unless she's pregnant or moving into menopause. But numerous things can wrong with the normal menstrual cycle.
Definition:
Menstruation means cyclic uterine bleeding caused by shedding of progestational endometrium it occurs between menarche and menopause
Menstruation (also called menstrual bleeding, menses, or a period)
Characteristics of normal menstruation
1-Menarche: 10-16 years. average 13 years.
2-Duration: 2-7 days (<2days>7 days is menorrhagia
3-Amount: 30-80 ml., uses 3 napkins per day, >80 ml. is menorrhagia and < 30 ml. is hypomenorrhea.
4-Normally menstrual blood doesn’t coagulate as a result of secretion of fibrinolysin enzyme (plasmin) secreted by the endometrium.
5-Menstrual molimina refers to mild symptoms of 7-10 days before menstruation relieved once menstruation occurs exaggerated condition called (premenstrual syndrome).
The hypothalamic-pituitary-ovarian axis:
There are two main components of the menstrual cycle,
1. the changes that happen in the ovaries in response to pituitary hormones (the ovarian cycle)
2. and the variations that take place in the uterus,
but it is important to remember that both cycles work together simultaneously to produce the menstrual cycle.
Changes in cervical mucus also take place during the course of the menstrual cycle.
This topic includes menstruation:- its definition, anatomical aspects- follicular growth and atresia, germ cells, premodial follicle; menstrual cycle/ ovarian cycle:- definition, phases- recruitment of groups of follicles (premature phase), selection of dominant follicle and its maturation, ovulation, follicular atresia; Endometrial cycle:- division of endometrium- basal zone, functional zone and its phases- stage of regeneration, stage of proliferation, secretory phase, menstrual phase, mechanism of menstrual bleeding, role of prostaglandins, hormones in relation to ovarian and menstrual cycle, ovulation, luteal-follicular shift, menstrual symptoms, menstrual hygiene, anovular menstruation, artificial postponement; cervical cycle, vaginal cycle and general changes in follicular and luteal phase.
This topic contains detailed description regarding Normal puerperium, it's definition, duration, phases, involution of uterus and other pelvic organs, lochia, general physiological changes of puerperium, lactation, management of normal puerperium, management of ailments and postnatal care.
It explains the mechanism of normal labour to medical and para-medical staff.It also puts light on principle movements underlying mechanism of normal labour with pictures.Thank You Like an share it to the maximum.
DEVELOPMENT OF PLACENTA,PLACENTA AT TERM , DECIDUA,PLACENTAL MEMBRANE , PLACENTAL CICULATION,PLACENTAL ENDOCRINE SYNTHESIS,ABNORMAL PLACENTA,FUNCTIONS.
DEFINITION OR MEANING OF MENSTRUAL (REPRODUCTIVE) CYCLE:-
Menstruation (Greek word, men-month) is monthly uterine bleeding out flowing through vagina into vulva for 4-5 days every 28 days (24-35 days)during reproductive life of a woman from menarche to menopause.
The Menstrual cycle of 28 days starts on day of onset of menstruation and ends at day 28 on start of next mens.
The cycle consists of a series of changes taking place concurrently in the ovaries and uterine lining, stimulated by changes in blood concentration of hormones.
This topic contains detailed description regarding Normal puerperium, it's definition, duration, phases, involution of uterus and other pelvic organs, lochia, general physiological changes of puerperium, lactation, management of normal puerperium, management of ailments and postnatal care.
It explains the mechanism of normal labour to medical and para-medical staff.It also puts light on principle movements underlying mechanism of normal labour with pictures.Thank You Like an share it to the maximum.
DEVELOPMENT OF PLACENTA,PLACENTA AT TERM , DECIDUA,PLACENTAL MEMBRANE , PLACENTAL CICULATION,PLACENTAL ENDOCRINE SYNTHESIS,ABNORMAL PLACENTA,FUNCTIONS.
DEFINITION OR MEANING OF MENSTRUAL (REPRODUCTIVE) CYCLE:-
Menstruation (Greek word, men-month) is monthly uterine bleeding out flowing through vagina into vulva for 4-5 days every 28 days (24-35 days)during reproductive life of a woman from menarche to menopause.
The Menstrual cycle of 28 days starts on day of onset of menstruation and ends at day 28 on start of next mens.
The cycle consists of a series of changes taking place concurrently in the ovaries and uterine lining, stimulated by changes in blood concentration of hormones.
Physiology for medical students in university.
Assignment done by students to be used for other university students also.
Focus more on the menstruation in female.
Why females living in one dorm menstruate at period and synchronization occur for their period.
Students can understand the reason why this occur and come to common understand the reason.
The menarche is one of the later stages of puberty in girls. The first period is called menarche . The average age of menarche in humans in 12years, but is normal anywhere between ages 8-16.
A number of physical and psychological changes take place at puberty:- The uterus , the uterine tubes and the ovaries reach maturity.
The menstrual cycle and ovulation begin {menarche},The breast develop and enlarge,Pubic and auxiliary hair begins to grow, Increases in height and widening of the pelvis. Increased fat deposited in the subcutaneous tissue especially at the hips and breasts. The cessation of menstrual cycles at the end of a woman's reproductive life is termed menopause. The average age of menopause in women is 51 years, with anywhere between 40-58 being common.
Menstruation is the periodic discharge of blood and sloughed endometrium (collectively called menses or menstrual flow) through the vagina.
The menstrual cycle is the regular natural change that occur in the female reproductive system (specially the ovaries and uterus) that makes pregnancy possible. This cycle is controlled by hormones, The menstrual cycle occurs because of a complex relationship between hormones from the brain and ovaries. This leads to the development and release of an egg from the ovary (ovulation) and growth of the internal lining (endometrium) of the uterus, to prepare it for pregnancy
Menarche is the first menstrual cycle, or first menstrual bleeding, in female human beings.
The average age of menarche is 11.75 years.
Menopause is the permanent cessation of menses.
Menopause typically (but not always) occurs in women during their late 40s or early 50s, and signals the end of the fertile phase of a woman's life.
The menarche is one of the later stages of puberty in girls. The first period is called menarche . The average age of menarche in humans in 12years, but is normal anywhere between ages 8-16.
A number of physical and psychological changes take place at puberty:- The uterus , the uterine tubes and the ovaries reach maturity.
The menstrual cycle and ovulation begin {menarche},The breast develop and enlarge,Pubic and auxiliary hair begins to grow, Increases in height and widening of the pelvis. Increased fat deposited in the subcutaneous tissue especially at the hips and breasts. The cessation of menstrual cycles at the end of a woman's reproductive life is termed menopause. The average age of menopause in women is 51 years, with anywhere between 40-58 being common.
Menstruation is the periodic discharge of blood and sloughed endometrium (collectively called menses or menstrual flow) through the vagina.
The menstrual cycle is the regular natural change that occur in the female reproductive system (specially the ovaries and uterus) that makes pregnancy possible. This cycle is controlled by hormones, The menstrual cycle occurs because of a complex relationship between hormones from the brain and ovaries. This leads to the development and release of an egg from the ovary (ovulation) and growth of the internal lining (endometrium) of the uterus, to prepare it for pregnancy
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
2. OUTLINE:
• Introduction
• Definition
• Characteristics of Normal Menstruation
• The Hypothalamic-pituitary-ovarian Axis
• Ovarian Cycle
• Uterine Cycle
• Menstrual Abnormalities
• Comfort Measures During Menstruation
2
3. INTRODUCTION
• Typically, a woman of childbearing age or
reproductive age (15-45) should menstruate every
28 days or so unless pregnant or in menopause.
• Numerous things can go wrong with the normal
menstrual cycle.
• The menstrual cycle is essential for the production
of ova, and for the preparation of the uterus for
pregnancy.
3
4. DEFINITION
• Menstruation is the periodic discharge of
blood, mucus and uterine cellular debris at
cyclic intervals from menarche to menopause.
• A.K.A: Period, Menses, Menstrual bleeding.
• Exception: Pregnancy, Lactation, Anovulation,
Pharmacological Interventions e.g.
contraceptive pills.
4
5. CHARACTERISTICS OF N.M
1. Menarche: 10–16 years (Average: 13 years).
2. Duration: 2–7 days.
• <2 days – Hypomenorrhea
• >7 days – Menorrhagia
3. Amount: 30–80 ml.
• Uses 3 napkins/pads per day
• <30ml – Hypomenorrhea
• >80ml – Menorrhagia
4. Cycle length: 21-35 days (Average: 28 days).
5
6. CHARACTERISTICS OF N.M CONT.
5. Normal menstrual blood doesn’t coagulate as
a result of secretion of fibrinolysin enzyme
(plasmin) secreted by the endometrium.
6. Menstrual molimina refers to mild symptoms
of 7-10 days before menstruation relieved
once menstruation occurs exaggerated
condition called Premenstrual Syndrome.
6
7. NOTE:
• Menopause: 45 – 55 years (Average: 51
years).
• Factors such as hereditary, diet and overall
health can accelerate or delay menarche.
• Irregular menstrual cycle is when the cycle
length is <21 days or >35 days.
7
9. THE HYPOTHALAMIC-
PITUITARY-OVARIAN AXIS
• The phases of the MC and ovulation are
regulated by interaction between
hypothalamus, anterior pituitary and ovaries.
• The interaction involves hormones.
ENDOCRINE GLAND HORMONES
Hypothalamus Gonadotropin Releasing Hormone
Anterior Pituitary Follicle-Stimulating Hormone (FSH) and
Hormone (LH).
Ovaries Estrogen and Progesterone
9
11. PHASES OF MENSTRUAL CYCLE
• There are two main components of the
menstrual cycle, the changes that
happens in the ovaries (Ovarian Cycle)
and the variations that take place in the
uterus (Uterine Cycle).
• The ovarian cycle is divided into three
phases; Follicular, Ovulatory and Luteal.
• The uterine cycle into three phases;
Menstrual, Proliferative and Secretory.
11
14. A. FOLLICULAR PHASE
• Follicular phase begins with menses on first day of
the menstrual cycle and ends with ovulation( Day 1
to Day 14 of 28-days cycle) .
• At the beginning of menstrual cycle, GnRH (pulsatile
manner) ➤ FSH and LH. FSH is responsible for the
recruitment and growth of several primordial follicle.
• Only one follicle on one of the ovaries reaches
maturity (Graafian follicle) which secretes estrogen.
14
15. A. FOLLICULAR PHASE CONT.
• Increase in estrogen level causes:
1. Negative feedback on the pituitary to stop
FSH
2. The uterine lining (endometrium) to grow
thicker
15
16. B. OVULATORY PHASE
• The estrogen peak stimulates secretion of LH,
leading to the LH peak which leads to the
follicle to burst open, releasing the mature
ovum, a process called ovulation.
• The remaining Graafian follicle forms Corpus
luteum.
• Ovulation occurs on day 14 of a 28-day cycle.
• High estrogen also suppress FSH secretion so
no further follicles grow.
16
17. C. LUTEAL PHASE
• After ovulation, LH levels remain elevated and
cause the remnants of the follicle to develop into a
yellow body called the corpus luteum.
• In addition to producing estrogen, the corpus
luteum secretes a hormone called progesterone.
• When progesterone reaches a high level it inhibits
the secretion of LH leads to degeneration of the
corpus luteum (If fertilization does not take place).
17
18. C. LUTEAL PHASE CONT.
• Degeneration of corpus luteum leads decrease in
estrogen and progesterone level and separation of
the endometrium (menstruation).
• Decrease in estrogen and progesterone level
stimulates the hypothalamus to secrete more
GnRH, a new cycle is started.
• If fertilization and implantation occurs, placenta
secretes human chorionic gonadotropin hormone
(hCG) which stimulates and maintain the corpus
luteum. hCG leads to positive urine pregnancy
test.
18
20. A. MENSTRUAL PHASE
• First day of the menstrual cycle is marked by the
onset of menstruation (period).
• During the menstrual phase of the uterine cycle,
the uterine lining is shed because of low levels of
progesterone and estrogen.
• At the same time, a follicle is beginning to develop
and starts producing.
• The menstrual phase ends when the menstrual
period stops on approximately day 5.
20
21. B. PROLIFERATIVE PHASE
• When estrogen levels are high enough, the
endometrium begins to regenerate.
• Estrogen stimulates blood vessels to develop.
The blood vessels in turn bring nutrients and
oxygen to the uterine lining, and it begins to
grow and become thicker.
• The proliferative phase ends with ovulation on
day 14.
21
22. C. SECRETORY PHASE
• After ovulation, the corpus luteum begins to
produce progesterone.
• This hormone causes the uterine lining to become
rich in nutrients in preparation for pregnancy.
• Estrogen levels also remain high so that the lining
is maintained.
• If pregnancy doesn’t occur, the corpus luteum
gradually degenerates, and the woman enters the
ischemic phase of the menstrual cycle.
22
23. C. SECRETORY PHASE
• Ischemic Phase - on days 27 and 28, estrogen
and progesterone levels fall because the corpus
luteum is no longer producing them.
• Without these hormones to maintain the blood
vessel network, the uterine lining becomes
ischemic.
• When the lining start slough, the woman has come
full cycle and is once again at day 1 of the
menstrual cycle.
23
26. A. CERVICAL MUCUS CHANGES
• Changes in cervical mucus takes place over the
course of the menstrual cycle.
• Some women use these characteristics to help
determine when ovulation is likely to happen.
• During the menstrual phase the cervix doesn’t
produce mucus.
• As the proliferative phase begins, the cervix begins
to produce a tacky, crumbly type of mucus that is
yellow or white.
26
27. A. CERVICAL MUCUS CHANGES
• As the time of ovulation becomes near, the
mucus becomes progressively clear, thin and
lubricative, with the properties of raw egg
white.
• At the peak of fertility(i.e., during ovulation), the
mucus has a distensible, stretchable called
spinbarkheit.
• After ovulation the mucus becomes scanty,
thick, and opaque.
27
29. B. BASAL BODY TEMPERATURE
• Basal body temperature (BBT or BTP) is the
lowest body temperature attained during rest
(usually during sleep).
• It is usually estimated by a temperature
measurement immediately after awakening
and before any physical activity has been
undertaken.
• Monitoring BBTs is one way of estimating the
day of ovulation
29
32. MENSTRUAL ABNORMALITIES
• Amenorrhea (no periods) is the absence of
uterine bleeding for more than 6 months in non-
menopausal women.
• Dysmenorrhea (painful periods) is the painful
menstruation, typically involving cramps.
• Hypomenorrhea is the regular menstruation
occurring at normal intervals, but with minimal
blood loss.
• Menorrhagia/Hypermenorrhea is the regular
menstruation occurring at normal intervals, but
with heavy blood loss.
32
33. MENSTRUAL ABNORMALITIES
• Menometrorrhagia is the uterine bleeding occurring at
irregular intervals, with heavy (>80mL) or prolonged
(>7days) menstrual flow.
• Oligomenorrhea is the uterine bleeding occurring at
intervals of 35 days or longer (every five weeks or more).
• Polymenorrhea is the uterine bleeding occurring at
intervals of 21 days or less (every three weeks or less).
• Postmenopausal bleeding is the uterine bleeding that
occurs after menopause.
33
34. MENSTRUAL ABNORMALITIES
• Premenstrual syndrome (PMS) is the
physical and psychological symptoms that
occur before the start of a period.
• Primary amenorrhea is absence for uterine
bleeding ever starting (at puberty).
• Secondary amenorrhea is absence of uterine
for more than 3 months after menarche.
34
35. CARE AND COMFORT MEASURES
Menstrual hygiene:
1. Sanitary pads and tampons:
• Wash hands before and after giving self-
perineal care.
• Washing or wiping the perineum should be
always done from front to back.
• Reduce use of tampons by substituting
sanitary pads especially at night.
• Use tampon only for heavy menstrual flow.
35
36. CARE AND COMFORT MEASURES
Menstrual hygiene:
2. Vaginal spray and douching:
• Spray should be used externally only not with pads.
• Should not be applied with broken irritated or itched
skin.
• Douching washes away the natural mucus and
upsets the vaginal ecology, thus make it liable to
infection.
36
37. REFERENCES
1. Dutta, D.C. and Hiralal Konar (2016). DC Dutta’s
textbook of gynecology : including contraception.
New Delhi: Jaypee
2. Hall, J. (2015). Guyton and Hall textbook of medical
physiology. Elsevier.
3. Wikipedia Contributors (2019). Menstrual cycle.
[online] Wikipedia. Available at:
https://en.wikipedia.org/wiki/Menstrual_Cycle.
4. All Image from google.com/images
37